Tender Details | ||||||||
|
||||||||
Deadline * | ||||||||
|
||||||||
Client Address | ||||||||
|
||||||||
More Information | ||||||||
Know More |
Similar Tenders
- Ref No: 3133479
- Location: Israel
Requests For Financial Participation Of The Ministry Of Energy In Conferences Seminars And Exhibitions
- Deadline: 31 Dec 2029
- Ref No: 3409221
- Location: United States
Uspsc Unit Lead For Civil Military Disaster Operations Division Cmd
- Deadline: 11 Nov 2024
- Ref No: 3418587
- Location: Ireland
2023 14 Re Advertisement For The Provision Of Erasmus Project Hosting Organisations Year 2
- Deadline: 09 Feb 2025
- Ref No: 3553648
- Location: United States
Commercial Solutions Opening Erdc Cold Regions Research And Engineering Laboratory
- Deadline: 30 Jan 2025
- Ref No: 3695292
- Location: United States
Services For Dhs Clients Under The Limited Supports Waiver
- Deadline: 01 Dec 2025
- Ref No: 3695311
- Location: United States
Individualized Residential Treatment Services For Persons With Intellectual Disabilities Phys
- Deadline: 31 Dec 2024
- Ref No: 3695345
- Location: United States
Fleet Vehicle Maintenance And Repair Services
- Deadline: 02 Feb 2026
- Ref No: 3969006
- Location: Germany
Conclusion Of A Non Exclusive Framework Agreement For Control Tests 2024Ff In The Open House Procedure Of The Northwest Branch
- Deadline: 31 Dec 2024
- Ref No: 3995591
- Location: Germany
Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingr
- Deadline: 31 Jan 2026
- Ref No: 3995810
- Location: France
Purchase Of Vehicles Cycles And Associated Services For The Occitanie Region
- Deadline: 21 Feb 2028
- Ref No: 3998161
- Location: Germany
Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingr
- Deadline: 31 Jan 2026
- Ref No: 3999046
- Location: Germany
Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingr
- Deadline: 31 Jan 2026